Caprock Group, Inc. Alkermes Plc. Transaction History
Caprock Group, Inc.
- $3.21 Billion
- Q1 2025
A detailed history of Caprock Group, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Caprock Group, Inc. holds 8,107 shares of ALKS stock, worth $253,019. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,107Holding current value
$253,019% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
176MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$908 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$568 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$368 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$250 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$215 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.13B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...